Home | Commonwealth Fund
Benchmarking U.S. health system performance against other high-income nations, and highlighting best practices from around the world, can help the U.S. face the challenge of mounting pressure of lowering health care costs while maintaining access to the latest in medical technologies, improving quality and safety, and making the health system more responsive to patients’ needs and preferences.
Actived: Thursday Jan 21, 2021
Reducing Wasteful Spending in Employers’ Pharmacy Benefit
Consider options for other programs to counter or take advantage of copayment coupons. 7. Adopt point-of-sale rebate practices to reduce cost burden on less healthy populations and to promote a degree of transparency about rebates and actual drug cost. 8. Identify provider groups treating large proportions of your population and partner with
Getting to the Root of High Prescription Drug Prices
Historic increases in prescription drug prices and spending are contributing to unsustainable health care costs in the United States. There is widespread public support for elected officials to address the problem. Congress and regulators can undertake a wide range of policy actions to begin to rebalance incentives for innovation and price competition, prioritize patient access and
Elijah E. Cummings Lower Drug Costs Now Act: How It Would
Prescription drug prices could fall significantly under the proposed Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) but how far they could fall would depend on several factors, including choices made in implementing the law and actions taken by drug manufacturers to minimize the reduction in their revenue.